Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|April 26, 2015
Quinazoline derivatives as anticancer drugs: a patent review (2011 - present)Séverine Ravez, Omar Castillo-Aguilera, Patrick Depreux, et al.
European Journal of Medicinal Chemistry|February 8, 2005
New antiproliferative benzoindolinothiazepines derivativesGuillaume Laconde, Patrick Depreux, Pascal Berthelot, et al.
Biomolecules|January 10, 2017
DNA Methylation Targeting: The DNMT/HMT Crosstalk ChallengeOmar Castillo-Aguilera, Patrick Depreux, Ludovic Halby, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 13, 2010
Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancerAntonio Garofalo, Laurence Goossens, Amelie Lemoine, et al.
Molecular Cancer Therapeutics|February 25, 2010
Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cellsMurielle Mimeault, Sonny L Johansson, Jean-Pierre Henichart, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Impact of aryloxy-linked quinazolines: a novel series of selective VEGFR-2 receptor tyrosine kinase inhibitorsAntonio Garofalo, Laurence Goossens, Perrine Six, et al.
European Journal of Medicinal Chemistry|April 22, 2014
Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitorsSéverine Ravez, Amélie Barczyk, Perrine Six, et al.
Pageof 3